Form 4: uniQure CMO Sells Shares for Tax Obligations

uniQure N.V.'s Chief Medical Officer, Walid Abi-Saab, sold 1,660 ordinary shares to cover tax withholding obligations related to restricted share unit vesting.

Summary

• Walid Abi-Saab, Chief Medical Officer of uniQure N.V., reported a sale of 1,660 ordinary shares.
• The transaction occurred on March 2, 2026, at a weighted average price of $9.95 per share, with prices ranging from $9.67 to $10.25.
• The sale was non-discretionary and executed solely to cover estimated withholding taxes upon the vesting of restricted share units, as per automatic sale instructions.
• Following this transaction, Mr. Abi-Saab beneficially owns 148,777 ordinary shares directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was non-discretionary and for tax purposes, not indicative of a change in the insider's investment sentiment.

Positives

• The sale was non-discretionary, indicating it was not a voluntary decision by the reporting person to reduce exposure to the company's stock.
• The number of shares sold (1,660) is a relatively small portion compared to the remaining beneficial ownership (148,777 shares).

Negatives

• A reduction in direct beneficial ownership, even if for tax purposes, slightly decreases the insider's direct stake in the company.

Future Outlook

Not applicable as this Form 4 filing details a past insider transaction and does not contain forward-looking statements or guidance.

Management Comments

• The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that routine, non-discretionary sales by executives to cover tax obligations upon restricted share unit (RSU) vesting are common across all industries and typically do not reflect a change in management's confidence in the company's future prospects.

Related Party Transactions

• The reported transaction is a related party dealing, involving the sale of company shares by a Chief Medical Officer.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary tax-related sale by an insider, not signaling a change in company fundamentals or insider confidence.

Key Dates

Recommendation

The filing details a routine, non-discretionary sale of shares by a Chief Medical Officer to cover tax obligations upon RSU vesting. This type of transaction is common and does not typically signal a change in the company's fundamental outlook or the insider's long-term confidence. Therefore, it provides no new information that would warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

uniQure N.V., QURE, Form 4, insider trading, stock sale, Chief Medical Officer, Walid Abi-Saab, restricted share units, tax withholding, beneficial ownership